Case Study:
Using Real World Data To Uncover Patient Journeys
Using Real World Data To Uncover Patient Journeys
The Client
The condition involved some changing dynamics with the introduction of some new drugs that changed the treatment approach. The client wanted to understand the impact this was having on the traditional patient journey and how the physicians were changing their treatment approach based on the new entrants.
The Solution
For this project we used multiple claims data sets that were longitudinal. Time series databases were also employed to speed up the process. In addition, Electronic Healthcare Record and Electronic Medical Record data were also available.
The Outcome
The various pathways of the patient journey were uncovered (as well as the critical tests done at each stage and which test results led to which next action and which drug class and which drug brand. Then we were able to add a consulting layer on top and identify specific leverage points at which the patient journey could be positively impacted towards our client drug (where appropriate for the patient).
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.
What the EU AI Act Postponement Actually Means for Pharma AI Governance Globally
The timeline moved. The governance burden did not. On 7 May 2026, the European Parliament and the Council reached a provisional political agreement on the
The Copilot Delusion: Why “We Only Use Copilot” Is Not an AI Governance Strategy
Choosing one tool and writing a policy around it feels like control. Under the regulations now shaping pharma AI, it answers the wrong question entirely.
From Use Case to Working AI Agent Inside Your Pharma Environment
There is a specific pattern emerging across the pharmaceutical industry. Functional leaders in regulatory affairs, medical affairs, commercial, and market access have now seen enough